Log in to your Inderes Free account to see all free content on this page.

Infant Bacterial Therapeutics

53.90 SEK

-3.75%

Less than 1K followers

IBT B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Infant Bacterial Therapeutics

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue
EBITDA-33.6-37.2-144.5-17.5-19.9-10.6-20.1-68.2
EBIT-33.8-37.4-145.3-17.5-20.1-10.8-20.5-69.0
EBIT-%
Profit before taxes-32.7-33.8-136.9-16.7-19.2-10.1-19.2-65.2
Net income-32.7-33.8-136.9-16.7-19.2-10.1-19.2-65.2
Login required

This content is only available for logged in users